Amgen’s Bkemv is the first interchangeable biosimilar to Soliris to treat certain rare diseases. The treatment of patients ...
Bringing the bispecific T-cell engager into the frontline consolidation phase "redefines the standard of care" for patients ...
A new Alzheimer’s drug from Eli Lilly was unanimously recommended for FDA approval by the FDA advisory committee. NBC News’ ...
The FDA's vaccine advisory panel voted to recommend that this fall’s Covid-19 shots should be updated to target Omicron’s ...
A U.S. Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the benefits of a new drug ...
The new weight-loss drug company emerged from stealth with big plans to take on obesity drugs like Wegovy and Zepbound.
On June 6, the U.S. Food and Drug Administration (FDA) approved Geron's first drug, imetelstat (brand name Rytelo), to treat ...
The FDA has made two approvals this week: the first interchangeable biosimilar of Soliris and another indication for Breyanzi ...
President Joe Biden and former President Donald Trump have seemingly found one issue they can agree on: Drug costs are too high. Each is crediting himself with price-busting policy successes that ...
Amgen (NASDAQ:AMGN) today announced the presentation of data across its diverse portfolio and pipeline at the European Alliance of Associations for Rheumatology's (EULAR) 2024 Congress, June 12-15 in ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ozempic and Wegovy (semaglutide for diabetes and weight loss, respectively) ...